ProShare Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $52.7M | Buy |
|
|||||
2025
Q1 | $39.3M | Buy |
|
|||||
2024
Q4 | $39.4M | Buy |
|
|||||
2024
Q3 | $29.2M | Buy |
|
|||||
2024
Q2 | $45.8M | Sell |
|
|||||
2024
Q1 | $60.2M | Buy |
|
|||||
2023
Q4 | $44.7M | Sell |
|
|||||
2023
Q3 | $39.7M | Buy |
|
|||||
2023
Q2 | $47.9M | Sell |
|
|||||
2023
Q1 | $46.2M | Buy |
|
|||||
2022
Q4 | $39.5M | Sell |
|
|||||
2022
Q3 | $31.4M | Sell |
|
|||||
2022
Q2 | $35.8M | Sell |
|
|||||
2022
Q1 | $91.1M | Sell |
|
|||||
2021
Q4 | $98.8M | Buy |
|
|||||
2021
Q3 | $63.8M | Buy |
|
|||||
2021
Q2 | $45.6M | Sell |
|
|||||
2021
Q1 | $41.4M | Buy |
|
|||||
2020
Q4 | $35.8M | Buy |
|
|||||
2020
Q3 | $32.9M | Buy |
|
|||||
2020
Q2 | $26.3M | Buy |
|
|||||
2020
Q1 | $446K | Sell |
|
|||||
2019
Q4 | $477K | Buy |
|
|||||
2019
Q3 | $320K | Sell |
|
|||||
2019
Q2 | $332K | Sell |
|
|||||
2019
Q1 | $430K | Buy |
|
|||||
2018
Q4 | $313K | Sell |
|
|||||
2018
Q3 | $446K | Buy |
|
|||||
2018
Q2 | $200K | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $219K | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $249K | Buy |
|
|||||
2015
Q3 | $251K | Sell |
|
|||||
2015
Q2 | $325K | Sell |
|
|||||
2015
Q1 | $1.14M | Sell |
|
|||||
2014
Q4 | $1.09M | Sell |
|
|||||
2014
Q3 | $1.28M | Sell |
|
|||||
2014
Q2 | $1.45M | Sell |
|
|||||
2014
Q1 | $2.96M | Buy |
|
|||||
2013
Q4 | – | Sell |
|
|||||
2013
Q3 | $1.26M | Buy |
|
|||||
2013
Q2 | $1M | Buy |
|